Drugs / TAK-828
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02817516 | Jun → Aug 2016 | — | Takeda | Terminated | No outcome recorded |
| Phase 1 | NCT02706834 | Mar → Jun 2016 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-828 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02706834 ↗ |
| Route | Oral | “single oral doses of TAK-828” NCT02706834 ↗ |